Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to skin and connective tissue diseases and pathological conditions. However, several previous location-related terms and specific disease resources have been removed.
    Difference
    6%
    Check dated 2025-08-30T15:42:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:22:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-09T07:56:05.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-02T04:13:35.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.3%
    Check dated 2025-07-26T00:35:07.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to include new topics related to antibodies, physiological effects of drugs, and immunologic factors, while the revision number has been changed from v2.16.5 to v2.16.6.
    Difference
    0.6%
    Check dated 2025-07-18T21:38:35.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.